Jaguar Health

Jaguar Health is an American commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for gastrointestinal (GI) distress, specifically chronic, debilitating diarrhea. It was incorporated in 2013 and is headquartered in San Francisco, California.
Jaguar Health stock price chart
-90%
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

Jaguar Health balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Jaguar Health cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Jaguar Health multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Jaguar Health profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Jaguar Health assets
Jaguar Health cash flows

Jaguar Health dividend policy

The company doesn't provide dividends

Jaguar Health shares

TickerNameTypeNominal valueISINPrice
JAGX:USJaguar HealthCommon share-US47010C6075$0.0719
Jaguar Health news
10.05.2022
Jaguar Health's GAAP loss for 3 months of 2022 was $18.164 million, up 51.3% from $12.009 million in the prior year. Revenue increased 2.11 times to $2.625 million from $1.241 million a year earlier.
14.03.2022
Jaguar Health's GAAP loss for 2021 was $52.6 million, up 55.6% from $33.809 million the previous year. Revenue declined 2.2 times to $4.335 million from $9.385 million a year earlier.
22.12.2021
Jaguar Health has received conditional FDA approval for the sale of Canalevia-CA1. The drug is designed to treat diarrhea in dogs caused by chemotherapy. Canalevia-CA1 was the first and only drug of its kind approved by the FDA.
General information
Company nameJaguar Health
Tags#biotechnology, #pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address200 Pine Street Suite 400 San Francisco, CA 94104 United States
Mailing address200 Pine Street Suite 400 San Francisco, CA 94104 United States
Websitejaguarhealth.gcs-web.com